DuPont H L, Capsuto E G
University of Texas Health Science Center, Houston, USA.
Clin Infect Dis. 1996 Jan;22(1):124-8. doi: 10.1093/clinids/22.1.124.
Most patients with traveler's diarrhea can be efficiently treated with available pharmacological agents. A more difficult problem is the persistent diarrhea (lasting > or = 14 days) that occurs in approximately 3% of travelers who have acute diarrhea. In the initial evaluation of these patients, ideally three stool samples should be obtained for examination for pathogens. If an agent is not identified or the patient has not responded to specific therapy, he or she may be empirically treated with an antimicrobial drug directed toward common bacterial enteropathogens, if such treatment has not already been administered. For those patients whose conditions do not respond, antiprotozoal therapy may be employed empirically. If diarrhea continues, then an endoscopic evaluation is indicated, and specific treatment can be given if an agent or condition is identified. A proportion of patients will continue to have diarrhea following empirical therapy and a gastroenterologic workup. These individuals are best given symptomatic treatment and reassured that the prognosis is good.
大多数旅行者腹泻患者可用现有的药物有效治疗。一个更棘手的问题是持续性腹泻(持续≥14天),约3%患急性腹泻的旅行者会出现这种情况。在对这些患者进行初步评估时,理想情况下应采集三份粪便样本检查病原体。如果未鉴定出病原体或患者对特定治疗无反应,若尚未进行此类治疗,可凭经验使用针对常见细菌性肠道病原体的抗菌药物进行治疗。对于那些病情无改善的患者,可凭经验采用抗原虫治疗。如果腹泻持续,则需进行内镜评估,若鉴定出病原体或病症,即可给予针对性治疗。一部分患者在经验性治疗和胃肠病检查后仍会持续腹泻。对这些人最好给予对症治疗,并让他们放心预后良好。